Nasdaq approves listing of first INJ staked ETF under ticker INJC.
Ecosystem ·
Nasdaq has approved the listing of the first staked INJ exchange-traded fund, which will trade under the ticker INJC. The approval marks a milestone for Injective, a layer-1 blockchain designed for on-chain financial markets, as it expands access to INJ through regulated U.S. venues. The token operates through deflationary tokenomics that direct protocol revenue into recurring burns and community buybacks, and Injective has positioned itself as infrastructure optimized for derivatives, orderbook exchanges, and tokenized assets rather than as a general-purpose smart contract platform.
The project has pursued regulatory alignment alongside technical development, with support from established crypto participants including Binance, Jump Crypto, and Pantera Capital. Recent momentum includes spot listing and staking availability on Binance.US, reinforcing Injective's presence in regulated American markets. The network emphasizes low-latency execution and cross-chain interoperability to serve what it frames as systemically important crypto activities—trading, real-world asset issuance, and structured product composition—at the base protocol layer rather than as optional applications.
The ETF approval does not yet clarify specifics such as launch timing, minimum investment thresholds, or the fund's operational structure. Broader regulatory clarity surrounding crypto markets and Injective's specific role in the derivatives and tokenized assets ecosystems also remains subject to ongoing developments.